Smartlab Europe

News

Ranbaxy Honored With Nabia Award For Excellence in New Jersey Business Expansion

Ranbaxy Inc., a research-based pharmaceutical company that manufactures generic product formulations, OTC and branded drug products, has been honored with the New Jersey Business Industry Association’s (NJBIA) Award for Excellence in Business Expansion and Economic Contribution to the...

AstraZeneca sticks to R&D partnership track in China

As global pharmas race to grab a piece of the growing Chinese drug market, London-based drug giant AstraZeneca appears to be sticking to an R&D strategy that emphasizes partnerships with local stakeholders over buyouts to gain traction in...

Sanofi Pasteur Donates Vaccine Strain Used for Polio Eradication to WHO

Sanofi Pasteur, the vaccines division of Sanofi is donating to the World Health Organization a vaccine strain used for polio eradication. The biological material given by Sanofi Pasteur is the original viral seed used to produce large quantities...

CMC Biologics, Inspiration team up to manufacture hemophilia B drug

Denmark based CMC Biologics and US based Inspiration Biopharmaceuticals have signed a supply agreement to manufacturing bulk IB1001 as a treatment and preventive measure of bleeding in individuals with hemophilia B. The agreement allows...

Nuevolution signs agreement with Boehringer

Nuevolution has signed an agreement with Boehringer Ingelheim to screen a range of small molecules for discovering and enhancing drug candidates by using Nuevolution's proprietary Chemetics drug discovery technology. The drugs which will be...

Moberg licenses OTC Nalox drug to Meda

Moberg Derma has given marketing license for its over-the-counter Nalox to Meda as a treatment for discolored and damaged nails caused by nail fungus or nail psoriasis. The new deal covers several major European...

Cellerant gets additional funding from BARDA

Cellerant Therapeutics has received additional funding of approximately $16.7m from Biomedical Advanced Research and Development Authority to advance CLT-008 development as a treatment for acute radiation syndrome . The additional funding is expected to...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »